Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12227)
All Articles published online
|
Publishing Process of This Article
|
Oct 8, 2015 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tabll A, Abbas AT, El-Kafrawy S, Wahid A. Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus. World J Hepatol 2015; 7(22): 2369-2383 [PMID: 26464752 DOI: 10.4254/wjh.v7.i22.2369] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i22/2369.htm |
| Number | Citing Articles |
| 1 |
Ashraf Tabll, Reem El-Shenawy, Yasmine El Abd. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70649
|
| 2 |
William B. Siegall, Rachel B. Lyon, Zvi Kelman. An important consideration when expressing mAbs in Escherichia coli. Protein Expression and Purification 2024; : 106499 doi: 10.1016/j.pep.2024.106499
|
| 3 |
Yu. A. Kuzyutina, I. B. Zakharova, D. V. Viktorov. Engineering E. coli recombinant strains for high yield production of Burkholderia pseudomallei specific antigens. Russian Journal of Infection and Immunity 2019; 9(1): 203 doi: 10.15789/2220-7619-2019-1-203-208
|
| 4 |
Ashraf A. Tabll, Sayed S. Sohrab, Ahmed A. Ali, Ana Petrovic, Sabina Steiner Srdarevic, Stjepan Siber, Marija Glasnovic, Robert Smolic, Martina Smolic. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens 2023; 13(1): 38 doi: 10.3390/pathogens13010038
|
| 5 |
Dalia T. Abdeldaim, Katharina Schindowski. Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. Pharmaceutics 2023; 15(10): 2402 doi: 10.3390/pharmaceutics15102402
|
| 6 |
Afiono Agung Prasetyo. VLPs of HCV local isolates for HCV immunoassay diagnostic approach in Indonesia. 2017; 1788: 030100 doi: 10.1063/1.4968353
|
| 7 |
Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd. Imran, Naira Nayeem. A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19. International Journal of Molecular Sciences 2021; 22(21): 11953 doi: 10.3390/ijms222111953
|
| 8 |
Srividhya Venkataraman, Kathleen Hefferon, Abdullah Makhzoum, Mounir Abouhaidar. Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?. Vaccines 2021; 9(7): 761 doi: 10.3390/vaccines9070761
|
| 9 |
Tianhe Li. Neutralizing scFv Antibodies against Infectious Bursal Disease Virus Isolated From a Nlpa-Based Bacterial Display Library. Annals of Advances in Chemistry 2017; 1(1): 001 doi: 10.29328/journal.aac.1001001
|
| 10 |
Ashraf A. Tabll, Yasser E. Shahein, Mohamed M. Omran, Mostafa M. Elnakib, Ameera A. Ragheb, Khaled E. Amer. A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection. Human Antibodies 2021; 29(3): 179 doi: 10.3233/HAB-200441
|
| 11 |
Noel Verjan Garcia, Ian Carlosalberto Santisteban Celis, Matthew Dent, Nobuyuki Matoba. Characterization and utility of two monoclonal antibodies to cholera toxin B subunit. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30834-2
|
| 12 |
Waller-Pulido Alejandra, Jiménez-Pérez Miriam Irene, Gonzalez-Sanchez Fabio Antonio, Rojo-Gutierrez Rocio Patricia, Torres-Anguiano Elizabeth, Juan Pablo Aleman-Aguilar, Garcia-Varela Rebeca. Production of monoclonal antibodies for therapeutic purposes: A review. International Immunopharmacology 2023; 120: 110376 doi: 10.1016/j.intimp.2023.110376
|
| 13 |
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
|
| 14 |
Asiabanha Rezaee Majid, Rasaee Mohammad Javad, Paknejad Malihe, Mohammadnejad Javad. Scale-up production and characterization of anti-human cardiac troponin I monoclonal antibody in ascitic fluid of balb/c mice. Journal of Immunoassay and Immunochemistry 2017; 38(4): 389 doi: 10.1080/15321819.2016.1274263
|
| 15 |
Shahin JAVANMARD. An Overview of The Various Appropriate Types of Cell Lines for The Production of Monoclonal Antibodies. Experimental and Applied Medical Science 2023; doi: 10.46871/eams.1254823
|
| 16 |
Soma Das, Ranajoy Mullick, Anuj Kumar, Himani Tandon, Mihika Bose, K Gouthamchandra, Madhavi Chandra, Bagepally Ravishankar, M. N Khaja, Narayanaswamy Srinivasan, Saumitra Das, Shaila Melkote Subbarao, Anjali Anoop Karande. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
Journal of General Virology
2017; 98(5): 962 doi: 10.1099/jgv.0.000735
|
| 17 |
Isah Ibrahim Abubakar, M. H. Ibrahim, Muhammad Y. Gwarzo, Binta G. Kurfi. CRYOPRESERVATION OF PRIMARY SPLENOCYTES FROM ANTIBODY PRODUCED MICE AGAINST Bitis arientans SNAKE VENOM. FUDMA JOURNAL OF SCIENCES 2023; 7(2): 235 doi: 10.33003/fjs-2023-0702-1688
|
| 18 |
Shruthi Sreekumar, Sidhartha D. Ray. Encyclopedia of Toxicology. 2024; : 503 doi: 10.1016/B978-0-12-824315-2.00683-7
|
| 19 |
Tobili Y. Sam-Yellowe. Immunology: Overview and Laboratory Manual. 2021; : 425 doi: 10.1007/978-3-030-64686-8_49
|
| 20 |
Mihika Bose, Ranajoy Mullick, Soma Das, Saumitra Das, Anjali A. Karande. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection. Virus Research 2016; 224: 46 doi: 10.1016/j.virusres.2016.08.010
|